INIS
cancer
100%
patients
67%
tumors
62%
lungs
51%
data
46%
learning
42%
radiomics
40%
artificial intelligence
29%
prediction
29%
lung cells
26%
validation
26%
images
23%
radiotherapy
22%
performance
21%
computed tomography
20%
biological markers
19%
risks
18%
nmr imaging
18%
datasets
18%
chest
17%
comparative evaluations
17%
values
14%
positron computed tomography
13%
humans
13%
volume
12%
diseases
12%
algorithms
12%
metastases
12%
adenocarcinomas
11%
assessments
11%
Keyphrases
Radiomics
33%
Artificial Intelligence
29%
Tumor
25%
Deep Learning
22%
Non-small Cell Lung Cancer (NSCLC)
19%
Lung Cancer
17%
Computed Tomography
12%
Area under the Curve
11%
Head-and-neck Cancer
10%
Lung Adenocarcinoma
10%
Overall Survival
10%
Radiotherapy
9%
Chest Radiograph
9%
Lung
9%
In Cancer
9%
Non-small Cell Lung Cancer Patients
8%
Cancer Imaging
7%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
7%
Positron Emission Tomography-computed Tomography (PET-CT)
6%
Colorectal Cancer
6%
Medical Imaging
6%
Imaging Data
6%
Tumor Heterogeneity
6%
Radiation Oncology
6%
Model Performance
6%
High-risk Human Papillomavirus (HR-HPV)
5%
Cardiovascular Risk
5%
Primary Tumor
5%
Convolutional Neural Network
5%
External Validation
5%
Medicine and Dentistry
Neoplasm
30%
Radiomics
27%
Non Small Cell Lung Cancer
20%
Malignant Neoplasm
19%
Lung Cancer
18%
Computer Assisted Tomography
15%
Radiation Therapy
15%
Magnetic Resonance Imaging
11%
Lung
9%
Biological Marker
8%
Overall Survival
8%
Oropharynx Carcinoma
8%
Thorax Radiography
8%
Immunotherapy
8%
Radiation Oncology
7%
Chemoradiotherapy
6%
Positron Emission Tomography
6%
Cardiovascular System
6%
Chest Radiograph
6%
Head and Neck Cancer
6%
Positron Emission Tomography-Computed Tomography
6%
Rectum Cancer
5%
Hazard Ratio
5%
